Scilex Holding (SCLXW) Interest Expenses (2021 - 2026)

Scilex Holding (SCLXW) recorded quarterly Interest Expenses of $3.8 million in Q1 2026, up 8.03% quarter-over-quarter from $3.5 million in Q4 2025, and up 52.32% on a YoY basis from $2.5 million in Q1 2025.

Scilex Holding (SCLXW) Interest Expenses (2021 - 2026) Analysis & Trends

Scilex Holding's Interest Expenses history runs 6 years deep, the most recent figure standing at $3.8 million for Q1 2026.

  • In Q1 2026, Interest Expenses rose 52.32% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $12.8 million (up 226.02% YoY), while the FY2025 annual figure was $11.5 million, up 483.75% from the prior year.
  • Interest Expenses was $3.8 million for Q1 2026 at Scilex Holding, up from $3.5 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $5.3 million in Q1 2023 to a low of $7466.0 in Q1 2022.
  • Historically, Interest Expenses has averaged $1.8 million across 5 years, with a median of $1.0 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Interest Expenses jumped 70513.45% in 2023, then plunged 89.93% in 2024.
  • A 5-year view of Interest Expenses shows it stood at $1.0 million in 2022, then plunged by 45.34% to $551000.0 in 2023, then sank by 48.28% to $285000.0 in 2024, then soared by 1127.37% to $3.5 million in 2025, then climbed by 8.03% to $3.8 million in 2026.
  • The last three Interest Expenses figures came in at $3.8 million (Q1 2026), $3.5 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -225.15 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 272.00 Mn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 657.00 Mn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 240.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -
10 Scilex Holding - - 4.15 Mn 3.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.78 Mn
Mar 31, 2026 3.78 Mn
Dec 31, 2025 3.50 Mn
Dec 31, 2025 3.50 Mn
Sep 30, 2025 2.80 Mn
Sep 30, 2025 2.80 Mn
Jun 30, 2025 2.68 Mn
Jun 30, 2025 2.68 Mn
Mar 31, 2025 2.48 Mn
Mar 31, 2025 2.48 Mn
Dec 31, 2024 285,000.00
Dec 31, 2024 285,000.00
Sep 30, 2024 576,000.00
Sep 30, 2024 576,000.00
Jun 30, 2024 571,000.00
Jun 30, 2024 571,000.00
Mar 31, 2024 531,000.00
Mar 31, 2024 531,000.00
Dec 31, 2023 551,000.00
Dec 31, 2023 551,000.00